The Infertility Treatment Devices and Equipment Market size is projected to reach US$ 3.23 billion by 2031 from US$ 1.39 billion in 2022. The market is expected to register a CAGR of 9.83% in 2023–2031. The development of novel infertility treatments such as intracytoplasmic sperm injection are likely to remain key infertility treatment devices and equipment market trends.

Infertility Treatment Devices and Equipment Market Analysis

Infertility is the inability to conceive after one year of unprotected sex. The World Health Organisation (WHO) has recognized it as a public health issue. The global infertility treatment devices and equipment market is experiencing significant growth due to various factors, including the decreasing global fertility rate, the higher success rate of advanced reproductive technologies, and the growing support from the government and other healthcare organizations. These factors are expected to favor the development of new treatments to improve fertility.  

Infertility Treatment Devices and Equipment Market Overview

As reported by the WHO, nearly 17.5% of the adults worldwide experience infertility. The lifetime prevalence of the condition was found to be 17.8% in high-income countries and 16.5% in low- and middle-income countries. Rising cases of infertility lead to a growth in the number of patients seeking infertility treatments. This highlighted the need for affordable, high-quality fertility care, which contributes to the expansion of the infertility treatment devices and equipment market.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

Get 10% FREE CUSTOMIZATION

Infertility Treatment Devices and Equipment Market: Strategic Insights

Infertility Treatment Devices and Equipment Market

• 
  CAGR (2023 - 2031)

  9.83%
• Market Size 2022
  US$ 1.39 Billion
• Market Size 2031
  US$ 3.23 Billion

Market Dynamics

GROWTH DRIVERS

• Increasing Infertility Rates

FUTURE TRENDS

• Technological Advancement

OPPORTUNITIES

• Rising Adoption of Minimally Invasive Devices

Key Players

• Thermo Fisher Scientific
• Cook Group
• Vitrolife
• IVFtech APS
• Hamilton Thorne Ltd.
• Esco Micro Pte Ltd
• Genea Biomedx Ltd
• FUJIFILM Irvine Scientific
• Eppendorf AG
• Baker Company INC.

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

Product Type

• Sperm Separation Devices
• Ovum Aspiration Pumps Sperm Analyzer Systems
• Micromanipulator Systems
• Incubators
• Others

Procedure

• Fertility Surgery
• Assisted Reproductive Technology
• Artificial Insemination

Procedure

• Fertility Surgery
• Assisted Reproductive Technology
• Artificial Insemination

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Infertility Treatment Devices and Equipment Market Drivers and Opportunities

High Success Rates of Advanced Infertility Treatment Technologies to Favor Market

Reproductive treatments have advanced significantly, expanding the options and success rates of infertility treatments such as Assisted Reproductive Technology (ART).  According to an article published in Cureus in October 2022, in the coming years, IVF is anticipated to be widely used across multiple regions globally, leading to the birth of up to 10% of all children and the success rates of In vitro maturation (IVM) have increased up to 56% due to technological advancements, improved necessary tools, and the accumulated experience and training of those performing the procedure. In addition, fertility awareness methods, like ovulation tracking apps, have become more accessible and reliable, enabling informed family planning decisions

Minimally Invasive Devices– An Opportunity in Infertility Treatment

Several abnormalities and conditions, including uterine fibroids, müllerian anomalies, ovarian cysts, and endometriosis, can reduce the chances of pregnancy. These issues can also cause unpleasant side effects, including chronic pelvic pain and heavy bleeding. Surgical intervention can be the most effective treatment for these symptoms in such cases. Adoption of minimally invasive techniques such as laparoscopy and hysteroscopy can address the underlying cause of infertility with reduced pain, recovery time, risk of infection, and blood loss. The procedures involve using small incisions and high-definition cameras that project the area of operation onto a monitor rather than large, open incisions used in conventional surgeries.

infertility treatment devices and equipment market Report Segmentation Analysis

Key segments contributing to the derivation of the infertility treatment devices and equipment Market analysis are product type, procedure, and end user.

• Based on product type, the infertility treatment devices and equipment Market is divided into sperm separation devices, ovum aspiration pumps, sperm analyzer systems, micromanipulator systems, incubators, and others. The ovum aspiration pumps segment held the largest market share in 2023.
• By procedure, the market is segmented into assisted reproductive technology, fertility surgery, and artificial insemination. The artificial insemination segment held the largest market share in 2023. Furthermore, the assisted reproductive technology segment is expected to register the highest CAGR from 2023 to 2031.
• In terms of end user, the market is segmented into fertility clinics, hospitals and other healthcare facilities, and clinical research institutes. The fertility clinics segment dominated the market in 2023.

Infertility Treatment Devices and Equipment Market Share Analysis by Geography

The geographic scope of the infertility treatment devices and equipment market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.

North America has dominated the infertility treatment devices and equipment market. According to the US Department of Health and Human Services, in 2021, around 2.3% of infants born in the US were conceived using ART, with ~ 413,776 cycles performed at 453 clinics, resulting in 112,088 pregnancies. The increasing number of AR procedures such as IVF, growing infertility rates among men, and the presence of global market players are factors contributing to the dominance of the North America infertility treatment devices and equipment Market. Asia Pacific is anticipated to grow with the highest CAGR in the coming years.

Infertility Treatment Devices and Equipment Market Report Scope

Download Free Sample

   Buy Now   

• Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.

Infertility Treatment Devices and Equipment Market News and Recent Developments

The infertility treatment devices and equipment market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for infertility treatment devices and equipment:

• Trajan Scientific and Medical supplied CE-IVD-registered Mitra devices to Fertilly, a German start-up. Fertilly launched Europe's first At-Home Fertility Test Kits using dried blood microsampling with VAMS technology. The Mitra microsampling devices allow for quick and easy collection of blood samples through finger sticks, which can then be mailed to a lab for analysis as dried blood. (Source: Trajan Scientific Australia Pty Ltd, Press Release, 2023)
• Merck Specialties Pvt ltd, the healthcare business of Merck in India, launched the Pergoveris Pen for advanced infertility treatment in India. This launch emphasizes the company’s motive of fulfilling unmet medical needs by providing an improved, convenient, and ready-to-use combination treatment option for women with severe follicle-stimulating hormone (FSH) and luteinizing hormone (LH) deficiency. (Source: Merck Specialties Pvt ltd, Press Release, 2021)

Infertility Treatment Devices and Equipment Market Report Coverage and Deliverables

The “Infertility Treatment Devices and Equipment Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
• Market dynamics such as drivers, restraints, and key opportunities
• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis
• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
• Detailed company profiles